CClinicalTrials.gg
CompletedNCT05402228Updated Jul 13, 2022

Investigation of the Aural Symptoms and Dizziness in Patients With Temporomandibular Joint Disorders

An observational study in Temporomandibular Joint Disorders, Dizziness and Tinnitus, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Completed at 2 sites in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-07-13.

Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years to 65 Years
Sex
All
01

Study summary

120 male and female patients aged between 18-65 years who apply to the outpatient clinic and diagnosed with TMD will be included in the study. Patients will be divided into 3 groups as Muscle Disorders (Group 1), Temporomandibular Joint Disorders (Group 2) and degenerative joint diseas (osteoarthrosis) (Group 3) according to DC/TMD axis I diagnostic criteria.

maximum mouth opening, TMJ sound, pain levels, tinnitus, and dizziness are evaluated.

Read the detailed description

120 male and female patients aged between 18-65 years who apply to the outpatient clinic and diagnosed with TMD will be included in the study. Patients will be divided into 3 groups as Muscle Disorders (Group 1), Temporomandibular Joint Disorders (Group 2) and degenerative joint diseas (osteoarthrosis) (Group 3) according to DC/TMD axis I diagnostic criteria.

Demographic data of all patients participating in the study will be obtained. Then, physical examination will reveal maximum mouth opening, right and left lateral movement, deflexion, deviation. Accompanying tinnitus, ear fullness and dizziness will be questioned.

All measurements, including maximum mouth opening, and physical examination will be performed with patients sitting upright in an anatomical position in a chair. All measurements will be performed by the same physical therapist with 7 years of experience in TMD.

In the measurement of maximum mouth opening, patients will be asked to open their mouths as wide as possible. The distance between the anterior incisors is measured with the help of a ruler suitable for millimeter measurement. Maximum mouth opening distance is a physical examination method frequently used to determine the motion and function of the jaw joint. Functional mouth opening is accepted as 35-40 mm (12).

For the evaluation of TMJ sound, the TMJ is palpated with the thumb and middle fingers and the sound heard when opening and closing the mesh is noted.

Pain levels are measured using a 10-point visual analog scale (VAS). The presence of bruxism is determined on physical examination based on the presence of abnormal tooth wear, tooth marks in the buccal region, tooth marks on the tongue, and hypertrophy of the masseter muscle.

The sense of fullness in the ear, tinnitus, and dizzyness, which the patients reported themselves, is questioned. The relationship between having TMD, clinical characteristics and dizziness will be evaluated.

02

Conditions studied

  • Temporomandibular Joint Disorders
  • Dizziness
  • Tinnitus

Keywords

  • temporomandibular joint
  • dizziness
  • aural sypmtoms
  • tinnitus
03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's enrollment of 120 is above the median of 100 across 216 observational studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 216 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

participants aged 18-65 years with TMD

Inclusion criteria

  • being 18-65 years of age
  • diagnosed with TMD

Exclusion criteria

Exclusion Criteria:

  • Lack of cognitive ability to understand test instructions, illliteracy, aphasia, presence of a known psychiatric illness
  • Patients under the age of 18 and over the age of 65
  • Having another systemic disease that will cause TMD (cancer, rheumatological diseases)
  • Presence of disease that will increase a anotherural symptoms or cause d d (presence of disease of vertigo, history of vertigo)
  • Presence of a history of cervical pain, cervical spondylosis, cervical disc herniation
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
120 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • Diagnostic testtemporomandbular joint disorders

    no intervention

06

What researchers measure

Primary outcomes

  1. maximum mouth opening

    maximum mouth opening

    Time frame: 1 day

  2. right and left lateral movement, deflexion, and deviation

    right and left lateral movement, deflexion, and deviation

    Time frame: 1 day

  3. TMJ sound

    the TMJis palpated with the thumb and middle fingers and the sound heard when opening and closing the mesh was noted.

    Time frame: 1 day

  4. visual analog scale

    It is use for evaluate the pain intensity.

    Time frame: 1 day

Secondary outcomes

  1. bruxism

    it is determined on physical examination based on the presence of abnormal tooth wear, tooth marks in the buccal region, tooth marks on the tongue, and hypertrophy of the masseter muscle.

    Time frame: 1 day

  2. the presence of bruxism, tinnitus and dizzeness

    the presence of bruxism, tinnitus and dizzeness

    Time frame: 1 day

07

Study locations

2 sites
  • Kanuni Sultan Suleyman Training and Research Hospital
    Istanbul, Kucukcekmece 34303, Turkey
  • Kanuni Sultan Suleyman Training and Research Hospital
    Istanbul, Kucukcekmece 34307, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05402228
Lead sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Collaborators
Kirsehir Ahi Evran Universitesi
Responsible party
Merve Damla Korkmaz (Medical Doctor, Kanuni Sultan Suleyman Training and Research Hospital) — Principal investigator
First posted
Jun 2, 2022
Start date
Mar 27, 2022
Primary completion
Jun 1, 2022
Completion
Jun 15, 2022
Last update
Jul 13, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion